Dynamics of CRISPR-Cas9 genome interrogation in living cells

Spencer C Knight1, Liangqi Xie2, Wulan Deng3

  • 1Department of Chemistry, University of California, Berkeley, CA, USA.

Science (New York, N.Y.)
|November 14, 2015
PubMed

Insights

The CRISPR-associated protein Cas9 uses 3D diffusion to search for DNA targets in mammalian cells. Its movement and sampling are influenced by the local chromatin environment, revealing its genome interrogation mechanism.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • The CRISPR-associated protein Cas9 (CRISPR-Cas9) is a powerful tool for genome editing, transcriptional modulation, and live-cell imaging.
  • CRISPR-Cas9 complexes target double-stranded DNA via RNA-DNA complementarity but the in vivo search mechanism in mammalian cells remains unclear.

Purpose of the Study:

  • To investigate the in vivo mechanism of target searching by Cas9 in mammalian cells.
  • To visualize the diffusion and chromatin binding dynamics of Cas9 in living cells.

Main Methods:

  • Single-particle tracking was employed to monitor the movement and chromatin interactions of Cas9 in live cells.
  • Analysis focused on diffusion patterns and the duration of off-target binding events.

Main Results:

  • Cas9 primarily utilizes three-dimensional diffusion for target searching within mammalian cells.
  • Off-target binding events are transient, lasting less than one second on average.
  • Cas9 movement and chromatin sampling are restricted in heterochromatin regions, indicating environmental dependence.

Conclusions:

  • The study elucidates the in vivo genome interrogation strategy of bacterial Cas9 in eukaryotic cells.
  • Cas9 navigates mammalian genomes by balancing diffusion with chromatin accessibility, influenced by local chromatin structure.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.4K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.6K
CRISPR01:59

CRISPR

No description available
18.8K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.0K